Patents by Inventor Samuel Graham

Samuel Graham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11524359
    Abstract: Disclosed herein are power electronic modules formed by directly bonding a heat sink to a dielectric substrate using transition liquid phase bonding.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: December 13, 2022
    Assignee: Georgia Tech Research Corporation
    Inventors: Waylon Puckett, Darshan G. Pahinkar, Samuel Graham
  • Publication number: 20200262000
    Abstract: Disclosed herein are power electronic modules formed by directly bonding a heat sink to a dielectric substrate using transition liquid phase bonding.
    Type: Application
    Filed: August 23, 2018
    Publication date: August 20, 2020
    Inventors: Waylon Puckett, Darshan G. Pahinkar, Samuel Graham
  • Publication number: 20070173525
    Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a benzazocine moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.
    Type: Application
    Filed: April 2, 2007
    Publication date: July 26, 2007
    Inventors: Annette Kim, Craig Stump, Christopher Dinsmore, Samuel Graham, Theresa Williams, Diem Nguyen, B. Trotter
  • Publication number: 20070021454
    Abstract: The present invention is directed to spiropiperidine compounds of formula (I) and tautomers thereof, which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.
    Type: Application
    Filed: July 14, 2006
    Publication date: January 25, 2007
    Inventors: Craig Coburn, Melissa Egbertson, Samuel Graham, Georgia McGaughey, Shaun Stauffer, Hemaka Rajapakse, Philippe Nantermet, Shawn Stachel, Wenjin Yang, Wanli Lu, Bruce Fahr
  • Publication number: 20060189600
    Abstract: The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    Type: Application
    Filed: March 10, 2004
    Publication date: August 24, 2006
    Inventors: Ian Bell, Samuel Graham, Theresa Williams, Craig Stump
  • Publication number: 20050239815
    Abstract: The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds of the instant invention possess a core structure that comprises a benzazocine moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.
    Type: Application
    Filed: April 8, 2003
    Publication date: October 27, 2005
    Inventors: Annette Kim, Craig Stump, Christopher Dinsmore, Samuel Graham, Theresa Williams, Diem Nguyen, B. Wesley Trotter
  • Publication number: 20050233656
    Abstract: The present disclosure relates to cementitious articles that are reinforced with a fabric made at least partially of high modulus polyolefin monofilament fibers. Preferably, the polypropylene monofilament yarns have a 3% secant modulus of elasticity of at least 100 g/denier. The high modulus polypropylene fabric has an intrinsic resistance to the alkaline conditions present in a cementitious composite, as well as a low elongation at break. The high modulus polypropylene may contain a nucleating agent to facilitate the process of obtaining desired draw ratio.
    Type: Application
    Filed: February 24, 2005
    Publication date: October 20, 2005
    Inventors: Joseph Royer, Randolph Kohlman, Samuel Graham
  • Publication number: 20050186409
    Abstract: A cement panel that is reinforced with a fabric made of nucleated polypropylene fibers. The cement panel includes a core layer that is made of a lightweight cement composition. This core layer is covered with a layer of reinforcing nucleated polypropylene fabric on the top and on the bottom, each bonded to the core with a coating of cementitious material on the top and on the bottom of the core layer. On the edges of the cement panels, the fabric layers may be overlapped so as to augment the strength of these edges.
    Type: Application
    Filed: February 25, 2004
    Publication date: August 25, 2005
    Inventors: Samuel Graham, Joseph Royer
  • Publication number: 20050137207
    Abstract: The present invention relates to methods of treating cancer using a combination of a compound which is an antineoplastic agent and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound which is an antineoplastic agent and a compound which is a inhibitor of prenyl-protein transferase. The invention also relates to methods of preparing such compositions.
    Type: Application
    Filed: February 15, 2005
    Publication date: June 23, 2005
    Inventors: Neal Rosen, Laura Sepp-Lorenzino, Mark Moasser, Allen Oliff, Jackson Gibbs, Nancy Kohl, Samuel Graham, George Prendergast
  • Publication number: 20040211448
    Abstract: Activated gaseous species generated adjacent a carbon contaminated surface affords in-situ cleaning. A device for removing carbon contamination from a surface of the substrate includes (a) a housing defining a vacuum chamber in which the substrate is located; (b) a source of gaseous species; and (c) a source of electrons that are emitted to activate the gaseous species into activated gaseous species. The source of electrons preferably includes (i) a filament made of a material that generates thermionic electron emissions; (ii) a source of energy that is connected to the filament; and (iii) an electrode to which the emitted electrons are attracted. The device is particularly suited for photolithography systems with optic surfaces, e.g., mirrors, that are otherwise inaccessible unless the system is dismantled.
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Applicant: EUV LLC
    Inventors: Leonard E. Klebanoff, Philip Grunow, Samuel Graham
  • Publication number: 20040011381
    Abstract: A method using atomic hydrogen for removing carbon contamination from optical surfaces. The method is particularly useful for removing carbon and hydrocarbon contamination in-situ from the surface of the multilayer optics used for extreme ultraviolet lithography (EUVL) without degrading the quality of the optical surface. Atomic hydrogen at pressures in the range of about 10−3 and 10−4 Torr without the potentially detrimental heating of the optic is used to provide cleaning rates of about 6-60 Å/hr.
    Type: Application
    Filed: July 17, 2002
    Publication date: January 22, 2004
    Inventors: Leonard E. Klebanoff, Samuel Graham
  • Publication number: 20030051739
    Abstract: Activated gaseous species generated adjacent a carbon contaminated surface affords in-situ cleaning. A device for removing carbon contamination from a surface of the substrate includes (a) a housing defining a vacuum chamber in which the substrate is located; (b) a source of gaseous species; and (c) a source of electrons that are emitted to activate the gaseous species into activated gaseous species. The source of electrons preferably includes (i) a filament made of a material that generates thermionic electron emissions; (ii) a source of energy that is connected to the filament; and (iii) an electrode to which the emitted electrons are attracted. The device is particularly suited for photolithography systems with optic surfaces, e.g., mirrors, that are otherwise inaccessible unless the system is dismantled.
    Type: Application
    Filed: September 18, 2001
    Publication date: March 20, 2003
    Inventors: Leonard E. Klebanoff, Philip Grunow, Samuel Graham